tirzepatide fda submission Grants a New Indication for Obesity Management How Medical Health Solutions is

Document consent, counselling and outcomes in the patient record

People who experienced significant wearing-off on semaglutide often find the effect more noticeable after switching to tirzepatide, not because tirzepatide is less effective, but because its shorter half-life creates a wider gap between peak and trough levels

Preference for daily pills (orforglipron) Most patients prefer taking daily pills over weekly injections due to the following reasons: No needles, no fear of injections: Needle aversion is a significant barrier for many patients

Furthermore, significant benefits were observed in functional capacity, with an 18.3-meter increase in the 6-minute walk distance compared to placebo

Bookmark this section, screenshot it, or print it and keep it near your supplies